Zdrowie i gospodarka · 23/07/2026

FDA Terminates and Reestablishes Peripheral and Central Nervous System Drugs Advisory Committee for 2 Years

The FDA is terminating and reestablishing the Peripheral and Central Nervous System Drugs Advisory Committee for 2 years, following its expiration on June 4, 2026, at the request of the Commissioner of Food and Drugs. The reestablishment is in the public interest, according to the Commissioner.